315 related articles for article (PubMed ID: 17996482)
1. Expression of cyclooxygenase-2 and DNA topoisomerase II alpha in precancerous and cancerous lesions of the oral mucosa.
Segawa E; Sakurai K; Kishimoto H; Takaoka K; Noguchi K; Hashitani S; Hirota S; Urade M
Oral Oncol; 2008 Jul; 44(7):664-71. PubMed ID: 17996482
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of cyclooxygenase-2 and DNA topoisomerase IIalpha expression in oral carcinoma.
Sakurai K; Urade M; Noguchi K; Hashitani S; Takaoka K; Segawa E; Kishimoto H
Head Neck; 2007 Nov; 29(11):1002-9. PubMed ID: 17427971
[TBL] [Abstract][Full Text] [Related]
3. Topoisomerase II alpha expression in esophageal squamous cell carcinoma.
Ohashi Y; Sasano H; Yamaki H; Shizawa S; Kikuchi A; Shineha R; Akaishi T; Satomi S; Nagura H
Anticancer Res; 1999; 19(3A):1873-80. PubMed ID: 10470130
[TBL] [Abstract][Full Text] [Related]
4. Cyclo-oxygenase-1 and -2 expression in human oral mucosa, dysplasias and squamous cell carcinomas and their pathological significance.
Shibata M; Kodani I; Osaki M; Araki K; Adachi H; Ryoke K; Ito H
Oral Oncol; 2005 Mar; 41(3):304-12. PubMed ID: 15743693
[TBL] [Abstract][Full Text] [Related]
5. Expression of cytosolic phospholipase A2 and cyclooxygenase 2 and their significance in human oral mucosae, dysplasias and squamous cell carcinomas.
Zhang S; Du Y; Tao J; Wu Y; Chen N
ORL J Otorhinolaryngol Relat Spec; 2008; 70(4):242-8. PubMed ID: 18467819
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical study on topoisomerase IIalpha, Ki-67 and cytokeratin-19 in oral lichen planus lesions.
Mattila R; Alanen K; Syrjänen S
Arch Dermatol Res; 2007 Jan; 298(8):381-8. PubMed ID: 17072627
[TBL] [Abstract][Full Text] [Related]
7. Topoisomerase II alpha expression in squamous cell carcinomas of the head and neck.
Stathopoulos GP; Kapranos N; Manolopoulos L; Papadimitriou C; Adamopoulos G
Anticancer Res; 2000; 20(1A):177-82. PubMed ID: 10769652
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical and two-parameter flow cytometric studies of DNA topoisomerase II alpha in human epithelial ovarian carcinoma and germ cell tumor.
Tanoguchi K; Sasano H; Yabuki N; Kikuchi A; Ito K; Sato S; Yajima A
Mod Pathol; 1998 Feb; 11(2):186-93. PubMed ID: 9504690
[TBL] [Abstract][Full Text] [Related]
9. DNA topoisomerase I and IIalpha expression in penile carcinomas: assessing potential tumour chemosensitivity.
Berney DM; Stankiewicz E; Adlan AM; Kudahetti S; Biedrzycki OJ; Hadway P; Watkin N; Corbishley C
BJU Int; 2008 Sep; 102(8):1040-4. PubMed ID: 18489530
[TBL] [Abstract][Full Text] [Related]
10. Expression of human DNA Topoisomerase II-alpha in squamous cell carcinoma of the larynx and its correlation with clinicopathologic variables.
Shvero J; Koren R; Shvili I; Yaniv E; Sadov R; Hadar T
Am J Clin Pathol; 2008 Dec; 130(6):934-9. PubMed ID: 19019771
[TBL] [Abstract][Full Text] [Related]
11. p73 expression for human buccal epithelial dysplasia and squamous cell carcinoma: does it correlate with nodal status of carcinoma and is there a relationship with malignant change of epithelial dysplasia?
Chen YK; Hsue SS; Lin LM
Head Neck; 2004 Nov; 26(11):945-52. PubMed ID: 15390192
[TBL] [Abstract][Full Text] [Related]
12. Expression of cyclo-oxygenase-2 in human tongue carcinoma and its precursor lesions.
Renkonen J; Wolff H; Paavonen T
Virchows Arch; 2002 Jun; 440(6):594-7. PubMed ID: 12070598
[TBL] [Abstract][Full Text] [Related]
13. The prognostic significance of proliferative activity, apoptosis and expression of DNA topoisomerase II alpha in multimodally-treated oesophageal squamous cell carcinoma.
Rees M; Stahl M; Klump B; Willers R; Gabbert HE; Sarbia M
Anticancer Res; 2001; 21(5):3637-42. PubMed ID: 11848536
[TBL] [Abstract][Full Text] [Related]
14. Sequential expression of inducible nitric oxide synthase and cyclooxygenase-2 during DMBA-induced hamster buccal pouch carcinogenesis.
Kim SA; Ahn SG; Kim DK; Kim SG; Lee SH; Kim J; Yoon JH
In Vivo; 2004; 18(5):609-14. PubMed ID: 15523901
[TBL] [Abstract][Full Text] [Related]
15. Cyclooxygenase-2 inhibition suppresses alphavbeta6 integrin-dependent oral squamous carcinoma invasion.
Nystrom ML; McCulloch D; Weinreb PH; Violette SM; Speight PM; Marshall JF; Hart IR; Thomas GJ
Cancer Res; 2006 Nov; 66(22):10833-42. PubMed ID: 17108119
[TBL] [Abstract][Full Text] [Related]
16. The expression of transforming growth factor-alpha in cirrhosis, dysplastic nodules, and hepatocellular carcinoma: an immunohistochemical study of 70 cases.
Yeh MM; Larson AM; Campbell JS; Fausto N; Rulyak SJ; Swanson PE
Am J Surg Pathol; 2007 May; 31(5):681-9. PubMed ID: 17460450
[TBL] [Abstract][Full Text] [Related]
17. Expression of DNA topoisomerase I and DNA topoisomerase II-alpha in carcinoma of the colon.
Staley BE; Samowitz WS; Bronstein IB; Holden JA
Mod Pathol; 1999 Apr; 12(4):356-61. PubMed ID: 10229499
[TBL] [Abstract][Full Text] [Related]
18. Topoisomerase II alpha expression correlates with diminished disease-free survival in invasive breast cancer.
O'Connor JK; Hazard LJ; Avent JM; Lee RJ; Fischbach J; Gaffney DK
Int J Radiat Oncol Biol Phys; 2006 Aug; 65(5):1411-5. PubMed ID: 16750309
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of Topoisomerase II in female breast cancer.
Koren R; Rath-Wolfson L; Ram E; Itzhac OB; Schachter B; Klein B; Gal R; Dreznik Z
Oncol Rep; 2004 Oct; 12(4):915-9. PubMed ID: 15375522
[TBL] [Abstract][Full Text] [Related]
20. Cyclooxygenase-2 expression in squamous cell carcinoma of the oral cavity and pharynx: association to p53 and clinical outcome.
Atula T; Hedström J; Ristimäki A; Finne P; Leivo I; Markkanen-Leppänen M; Haglund C
Oncol Rep; 2006 Sep; 16(3):485-90. PubMed ID: 16865247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
